
Once-a-Year Wonder: New Drug Revolutionizes Cholesterol Treatment!
A groundbreaking one-dose drug, lepodisiran, is turning the tide in the fight against genetic bad cholesterol. Its ability to reduce lipoprotein(a) levels drastically could redefine cardiovascular disease treatment. We’ll dive into the science of this promising therapy and what it means for patients worldwide.